Overall, these data suggest that PBMCs from lymphoma patients at diagnosis include a population of CD66b+CD33dimHLA-DR− cells, mostly composed of mature activated CD11b+CD16+ LDNs, which can be defined as G-MDSCs given their suppressive properties on T cell proliferation. This evidence concerns the gene ITGAM and lymphoma.